HollySys Asia Pacific to Provide Integrated Supervisory Control System for Thomson & Eastern Region Lines in Singapore

HollySys (Asia Pacific) Pte Ltd, a leading provider of automation and control technologies and applications in Asia, announced today that it successfully signed a contract with Land Transport Authority ("LTA") in Singapore to provide the subway with an Integrated Supervisory Control System for the Thomson & Eastern Region Lines in Singapore, and the contract size is approximately SGD16 million.

Integrated Supervisory Control System, also named as Supervisory Control and Data Acquisition System ("SCADA"), is an integrated open software and hardware platform that allows different types of automation sub-systems including power system, alarm system, monitor system, passenger info, access control, broadcasting systems and etc. in the subway stations to be connected on the same control panel via coded signals over communication channels, to enable a comprehensive supervision and control of the systems in the subway stations. HollySys is providing its core proprietary software technology of the Integrated Supervisory Control System and its proprietary Programmable Logic Controllers ("PLC") for this line.

The 30-km long Thomson Line will be fully underground with 22 stations, including six interchange stations. The Eastern Region Line will run together with the Thomson Line as one line when completed. The LTA will announce more details regarding the Eastern Region Line at a later date.

Hollysys' management commented: "We are pleased to have won this contract to supply the subway SCADA system for Thomson & Eastern Region Lines, which is a major breakthrough for Hollysys in the international subway SCADA system market and helps us further penetrate into the local market and world at large. This contract win is the joint efforts by Hollysys Group Rail Transportation team and Concord team leveraging their proprietary technology, design and software customization, project management and project execution capabilities respectively, which create solid synergy in promoting our overseas business. In the future, Hollysys will continue to expand the subway related business opportunities in the Southeast Asia market, leveraging its strong R&D capability, effective management, high-quality products and services and customer recognition to further grow its international business and create value for our shareholders."

About Hollysys Automation Technologies, Ltd. (NASDAQ: HOLI)

Hollysys Automation Technologies is a leading provider of automation and control technologies and applications in China that enables its diversified industry and utility customers to improve operating safety, reliability, and efficiency. Founded in 1993, Hollysys has approximately 3,800 employees with nationwide presence in over 60 cities in China, with subsidiaries and offices in Singapore, Malaysia, Dubai, India, and serves over 5,000 customers more than 20,000 projects in the industrial, railway, subway & nuclear industries in China, South-East Asia, and the Middle East. Its proprietary technologies are applied in its industrial automation solution suite including DCS (Distributed Control System), PLC (Programmable Logic Controller), RMIS (Real-time Management Information System), HAMS (HolliAS Asset Management System), OTS (Operator Training System), HolliAS BATCH (Batch Application Package), HolliAS APC Suite (Advanced Process Control Package), SIS (Safety Instrumentation System), high-speed railway signaling system of TCC (Train Control Center), ATP (Automatic Train Protection), Subway Supervisory and Control platform, SCADA (Surveillance Control and Data Acquisition), nuclear power plant automation and control system and other products.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.